| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | ISRG Intuitive Surgical Inc | Curet Myriam56 | EVP &Chief Medical Officer | Sell | 481 | $386.09 | $185,709.29 | -61.7% | -0.3% | +54.8% | |
| Feb 9, 2024 | SYK Stryker Corp | Boehnlein Glenn S | VP, Chief Financial Officer | Sell | 9,600 | $342.81 | $3,290,952.00 | -32.2% | -3.2% | +14.5% | |
| Feb 9, 2024 | STIM Neuronetics, Inc. | Furlong Stephen74 | EVP, CFO And Treasurer | Sell | 14,710 | $3.51 | $51,632.10 | -2.8% | -30.8% | -14.7% | |
| Feb 9, 2024 | RXST Rxsight, Inc. | Goldshleger Ilya81 | Chief Operating Officer | Sell | 10,365 | $50.74 | $525,938.94 | -15.2% | +23.4% | -33.6% | |
| Feb 9, 2024 | GKOS Glaukos Corp | Gilliam Joseph E55 | President &COO | Sell | 5,631 | $96.14 | $541,367.70 | -2.3% | +11.8% | +59.0% | |
| Feb 9, 2024 | PRCT Procept Biorobotics Corp | Nouri Alaleh50 | EVP, CLO, Corp. Sec. | Sell | 20,000 | $49.97 | $999,366.82 | -17.4% | +26.2% | +39.3% | |
| Feb 9, 2024 | PRCT Procept Biorobotics Corp | Waters Kevin | EVP, CFO | Sell | 29,581 | $50.09 | $1,481,579.31 | -30.6% | +26.2% | +39.3% | |
| Feb 8, 2024 | EW Edwards Lifesciences Corp | Stone Heisz Leslie55 | Director | Sell | 7,056 | $86.45 | $609,991.20 | -20.7% | -0.8% | -18.0% | |
| Feb 8, 2024 | IDXX Idexx Laboratories Inc /de | Fennell George | SVP, Chief Revenue Officer | Sell | 8,198 | $573.87 | $4,704,558.69 | -14.3% | -15.1% | -19.8% | |
| Feb 8, 2024 | GKOS Glaukos Corp | Thurman Alex R.50 | SVP &Chief Financial Officer | Sell | 583 | $95.74 | $55,816.71 | -0.4% | +11.4% | +59.5% | |
| Feb 7, 2024 | ISRG Intuitive Surgical Inc | Rosa David J.54 | President | Sell | 80,710 | $389.28 | $31,418,467.95 | -7.9% | -0.7% | +50.4% | |
| Feb 7, 2024 | IDXX Idexx Laboratories Inc /de | McKeon Brian P69 | EVP, CFO And Treasurer | Sell | 23,326 | $570.01 | $13,295,974.99 | -5.6% | -15.5% | -19.5% | |
| Feb 7, 2024 | ALGN Align Technology Inc | Wright Emory62 | EVP, Global Operations | Sell | 2,524 | $287.45 | $725,533.00 | -26.3% | +0.6% | -23.3% | |
| Feb 7, 2024 | IDXX Idexx Laboratories Inc /de | Mazelsky Jonathan Jay63 | President And CEO | Sell | 12,000 | $572.61 | $6,871,319.17 | -2.9% | -15.5% | -19.5% | |
| Feb 7, 2024 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 736 | $90.09 | $66,306.24 | -4.9% | +44.4% | -16.6% | |
| Feb 7, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 13,320 | $1.17 | $15,570.19 | - | -8.8% | -33.9% | |
| Feb 6, 2024 | SERA Sera Prognostics, Inc. | Harrison Robert Gardner74 | Chief Information Officer | Sell | 5,665 | $8.03 | $45,489.95 | -3.7% | +19.4% | -39.4% | |
| Feb 6, 2024 | SERA Sera Prognostics, Inc. | Aerts Austin77 | Chief Financial Officer | Sell | 9,786 | $8.03 | $78,581.58 | -2.9% | +19.4% | -39.4% | |
| Feb 6, 2024 | SERA Sera Prognostics, Inc. | Lindgardt Zhenya75 | Chief Executive Officer | Sell | 27,997 | $8.03 | $224,815.91 | -2.9% | +19.4% | -39.4% | |
| Feb 6, 2024 | SERA Sera Prognostics, Inc. | Kearney Paul78 | Chief Data Officer | Sell | 4,984 | $8.03 | $40,021.52 | -3.0% | +19.4% | -39.4% | |
| Feb 6, 2024 | TMDX Transmedics Group, Inc. | Basile Edward M64 | Director | Sell | 7,157 | $86.38 | $618,209.43 | -28.4% | +53.0% | -14.0% | |
| Feb 6, 2024 | SERA Sera Prognostics, Inc. | Jackson Benjamin81 | General Counsel | Sell | 5,665 | $8.03 | $45,489.95 | -3.6% | +19.4% | -39.4% | |
| Feb 6, 2024 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 5,665 | $8.03 | $45,489.95 | -2.9% | +19.4% | -39.4% | |
| Feb 6, 2024 | RXST Rxsight, Inc. | Thunen Shelley B74 | Chief Financial Officer | Sell | 25,000 | $47.31 | $1,182,660.25 | -47.7% | +32.3% | -27.9% | |
| Feb 6, 2024 | STIM Neuronetics, Inc. | MacAn William Andrew66 | EVP, GC, CCO And Cs | Sell | 5,385 | $3.39 | $18,255.15 | -1.2% | +6.5% | -7.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.